Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Altimmune Inc.

    NASDAQ: ALT · Real-Time Price · USD
    6.93
    -0.22 (-3.08%)
    At close: Jun 13, 2025, 3:59 PM
    6.92
    -0.14%
    After-hours: Jun 13, 2025, 05:59 PM EDT

    Altimmune Statistics

    Share Statistics

    Altimmune has 81.11M shares outstanding. The number of shares has increased by 8.62% in one year.

    Shares Outstanding

    n/a
    		 81.11M

    Shares Change (YoY)

    n/a
    		 8.62%

    Shares Change (QoQ)

    n/a
    		 8.28%

    Owned by Institutions (%)

    n/a
    		 56.91%

    Shares Floating

    n/a
    		 80.26M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,286

    FTD / Avg. Volume

    n/a
    		 0.05%

    Short Selling Information

    The latest short interest is 21.98M, so 27.1% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 21.98M

    Short % of Shares Out

    n/a
    		 27.1%

    Short % of Float

    n/a
    		 27.31%

    Short Ratio (days to cover)

    n/a
    		 10.97

    Valuation Ratios

    The PE ratio is -5.39 and the forward PE ratio is -4.85. Altimmune's PEG ratio is 0.28.

    PE Ratio

    n/a
    		 -5.39

    Forward PE

    n/a
    		 -4.85

    PS Ratio

    n/a
    		 25596.73

    Forward PS

    n/a
    		 0.7

    PB Ratio

    n/a
    		 4.14

    P/FCF Ratio

    n/a
    		 -6.41

    PEG Ratio

    n/a
    		 0.28
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Altimmune.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 13.11, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 13.11

    Quick Ratio

    n/a
    		 13.11

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 -11463.56

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $338.98

    Profits Per Employee

    n/a
    		 $-1,611,169.49

    Employee Count

    n/a
    		 59

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 7.87% in the last 52 weeks. The beta is 0.57, so Altimmune's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.57

    52-Week Price Change

    n/a
    		 7.87%

    50-Day Moving Average

    n/a
    		 5.27

    200-Day Moving Average

    n/a
    		 6.55

    Relative Strength Index (RSI)

    n/a
    		 71.66

    Average Volume (20 Days)

    n/a
    		 2,642,168

    Income Statement

    In the last 12 months, Altimmune had revenue of 20K and earned -95.06M in profits. Earnings per share was -1.34.

    Revenue

    n/a
    		 20K

    Gross Profit

    n/a
    		 20K

    Operating Income

    n/a
    		 -103.17M

    Net Income

    n/a
    		 -95.06M

    EBITDA

    n/a
    		 -94.81M

    EBIT

    n/a
    		 -95.05M

    Earnings Per Share (EPS)

    n/a
    		 -1.34
    Full Income Statement

    Balance Sheet

    The company has 36.93M in cash and 1.68M in debt, giving a net cash position of 35.24M.

    Cash & Cash Equivalents

    n/a
    		 36.93M

    Total Debt

    n/a
    		 1.68M

    Net Cash

    n/a
    		 35.24M

    Retained Earnings

    n/a
    		 -561.39M

    Total Assets

    n/a
    		 157.26M

    Working Capital

    n/a
    		 145.46M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -79.85M and capital expenditures 0, giving a free cash flow of -79.85M.

    Operating Cash Flow

    n/a
    		 -79.85M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -79.85M

    FCF Per Share

    n/a
    		 -1.12
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -515860% and -475295%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -515860%

    Pretax Margin

    n/a
    		 -475295%

    Profit Margin

    n/a
    		 -475295%

    EBITDA Margin

    n/a
    		 -474060%

    EBIT Margin

    n/a
    		 -515860%

    FCF Margin

    n/a
    		 -399240%

    Dividends & Yields

    ALT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ALT is $22.5, which is 215.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $22.5

    Price Target Difference

    n/a
    		 215.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Sep 14, 2018. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 Sep 14, 2018

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 12.14

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist